Women Informed to Screen Depending on Measures of Risk (Wisdom Study) (WISDOM)
Breast Cancer Screening, Breast Carcinoma in Situ, Breast Cancer
About this trial
This is an interventional screening trial for Breast Cancer Screening focused on measuring Breast screening, mammography, prevention, risk assessment, DCIS, Breast cancer, Wisdom
Eligibility Criteria
Inclusion Criteria:
- Female*
- Age 40 years to 74 years old
- Reside in California, North Dakota, South Dakota, Iowa, Minnesota, Alabama, Louisiana, Illinois OR have coverage from a participating health plan**.
NOTE*: As of 2019, we are now enrolling all persons who identify as female, and will capture both their sex at birth and gender identity in the baseline survey.
NOTE**: Depending on funding for study services, recruitment will expand nationwide, therefore criteria (c) will not apply if funding allows. As of 2019, recruitment is available nationwide.
Exclusion Criteria:
- Prior Breast cancer or ductal carcinoma in situ (DCIS) diagnosis
- Prior prophylactic bilateral mastectomy
- Inability to provide consent
- Non-English or Spanish proficiency (Spanish participation available: June 2019)
Sites / Locations
- University of Alabama at BirminghamRecruiting
- University of California IrvineRecruiting
- University of California Los AngelesRecruiting
- University of California DavisRecruiting
- University of California San DiegoRecruiting
- University of California San FranciscoRecruiting
- TopLine MD AllianceRecruiting
- University of ChicagoRecruiting
- Louisiana State UniversityRecruiting
- Weill Cornell MedicineRecruiting
- Edith Sanford Breast CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Annual Arm
Risk-Based Arm
Women in this arm will receive Athena standard of care mammography screening, including annual mammograms. They will complete a health questionnaire and receive screening advice based on a basic risk assessment.
Women in this arm will receive risk-based screening, where risk is calculated based on a model including personal history, family history, and genetic testing. All women in the risk-based arm complete a health questionnaire, provide a saliva sample for genetic testing, and receive screening advice based on a comprehensive risk assessment. Women in this arm will be tested for a panel of 9 genes related to breast cancer risk as well as a panel of SNPs, which can further modify risk. Women will be assigned a screening start date, screening stop date, and screening frequency.